• About
  • Subscribe
  • Advertise
  • Contact
Thursday, February 12, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Feature

Lens supplier switch pays dividends for Nepean Optical (VIC)

by Myles Hume
June 7, 2024
in Feature, Ophthalmic lenses, Ophthalmic Treatments, Report
Reading Time: 7 mins read
A A
The DNEye Scanner is now a central instrument at Nepean Optical. The independent practice is located in Rosebud on Victoria’s Mornington Peninsula. Images: Nepean Optical.

The DNEye Scanner is now a central instrument at Nepean Optical. The independent practice is located in Rosebud on Victoria’s Mornington Peninsula. Images: Nepean Optical.

Share on FacebookShare on Twitter

Every practice would love to see an uptick in productivity, precision and profitability – but what if it
was as simple as a single business decision? This was the case for a Victorian seaside independent that recently switched to a new lens supplier. 

Nepean Optical on Victoria’s Mornington Peninsula has always sought to offer high quality lenses and technologies, continually upgrading to keep pace with innovation. The business has always done well, but has been blown away by the immediate returns since going all-in on a new lens manufacturer. 

Seven months ago, the practice started introducing technology from German ophthalmic lens company Rodenstock. Beyond carrying the manufacturer’s trademark lenses, Nepean Optical has installed the company’s ImpressionIST eyewear centration tower and its hero device – the DNEye Scanner 2 – that creates a biometric model of the eye used to calculate the final lens. Bringing all of this together, the business uses Rodenstock’s CNXT program that transfers patient measurement data automatically and in real time between devices. 

“We have always ensured we provide our customers with high quality lenses and technologies, continuing to upgrade and invest in the more advanced processes and designs available in the market. But the Rodenstock technology, the processes and the patient journey is beyond what we have been able to offer before,” says Nepean Optical principal optometrist and owner Mr Michael Mether. 

“As business owners, ROI is not just considering the financial benefits but also justifying patient satisfaction and benefits. Being able to offer a competitive edge is a priority for us, and providing superior quality for our patient base is integral to our practice values. The Rodenstock technology has streamlined the process which has enhanced our productivity, precision and improved profitability.”

Image: Nepean Optical.

For practices offering the very best of Rodenstock’s lenses, the DNEye Scanner is the lynchpin. Within a matter of seconds, it takes more than 7,000 measurements of 80 parameters to ultimately produce a unique biometric lens for the patient. These premium, tier one lenses are known as B.I.G. EXACT, and are helping practices like Nepean Optical to elevate and differentiate their service. 

But the DNEye device has also helped the lens manufacturer create a second tier lens, B.I.G. NORM, that uses AI trained on more than 500,000 DNEye scans. By harnessing correlations in data from the subjective refraction – sphere, cylinder, axis, and addition – Rodenstock has been able to offer another highly personalised lens design at a lower cost. 

“Rodenstock has introduced many firsts to the world of optics and with the unique DNEye Scanner being the world’s most innovative eye test it was an easy decision,” Mether says. 

“The DNEye allows us to offer our patients the only true biometric lenses in the world and this is extremely exciting for us as professionals knowing we are working with the best to provide our patients with the best in both clinical care and individualised products.”

By installing the full gamut of Rodenstock technology, Mether says the practice can now offer a truly unique patient experience.

At Nepean Optical, the patient journey begins in the pre-test room where time is allowed to educate patients on the process of the DNEye scanner and the individualised information it collects. Then, the optometrists carry this through to the examination room to discuss and review the data on the CNXT system. The optical dispensing team then complete the journey with the ImpressionIST tower where the patient is precisely measured for all position of wear calculations. 

“All of our Rodenstock technology has enhanced brand and practice reputation, helped us to create a point-of-difference in the market and given our patients access to the most technologically advance products. Patient satisfaction and retention has increased. All of those are critical in the optometry landscape today,” Mether says. 

Rodenstock’s DNEye Scanner drew plenty of interest at Melbourne’s O=MEGA23 conference in September 2023. Image: ODMA.

In terms of where the lenses have delivered the most impact, Nepean Optical has had positive feedback from a vast array of patients. With a larger percentage of its patients being presbyopic, this is where the practice has seen the best results in progressive lenses, but those with higher prescriptions and astigmatism have also proved extremely successful.

“Common patient responses include noticeably much sharper vision along with less peripheral distortion and better motion perception,” Mether says. “And customers are returning to seek further information about the technology they have received in their lenses so they can tell family and friends.”

Nepean Optical’s Rodenstock rollout  

Not only is switching to an entire new lens brand a significant financial investment, but a major commitment to new workflows, processes and terminology for practice staff.

Ms Nicola Peaper, national professional services manager at Rodenstock Australia, is a key figure during the installation and integration process for independent customers. The goal is to be thorough enough so staff have the confidence to dispense the lenses, while providing minimal disruption to the business. 

Mether says between Peaper and her depth of knowledge, Rodenstock’s account manager, IT support and the laboratory staff, the practice has felt well supported during a phased integration.

“The transition to Rodenstock has surprisingly been easy. We endeavoured to keep the transition as simple as possible initially with our lens offerings, introducing more products and designs over time to allow our thorough understanding and confidence in what we were offering our customers,” Mether says. 

“Training with the Rodenstock team on their products and equipment has allowed our staff to embrace and thrive with this transition. Knowing a Rodenstock team member is only a phone call away if needed has provided great ease and confidence with the transition.”

Beyond improved spectacle lens outcomes, Nepean Optical has also found the DNEye Scanner fills other needs in its practice. The device has multiple functions including aberrometry, topography, pachymetry, and tonometry, meaning it can provide other clinical insights.

For example, Mether finds pachymetry results, anterior chamber and angle scans useful for glaucoma triage. Axial length calculation has a benefit for myopia progression analysis, and corneal mapping is helpful for asking further questions as to why visual acuity may not match expectations. This message can then be explained visually to the patient.

“The lens opacity function is also very demonstrative to patients as to why they cannot see properly,” Mether explains. 

“Auto refraction gives so many clues as to the final refractive error measurements and really speeds up the process and confidence of refractive error findings. The vision simulator function is able to illustrate what the patient sees without spectacles, and why they have the symptoms they have, and the benefit of vision correction.”

Established in 1990, Nepean Optical has prided itself on comprehensive eyecare and services – including behavioural optometry and vision therapy – with a focus on advanced diagnostics and personalised treatment plans for patients. Its patient demographic is wide ranging from infants and young children to older generations. 

By offering Rodenstock technology, the staff have been able to heighten their delivery of tailored, personalised eyecare, providing only the best experience they can during the examination and beyond. This mindset, according to Mether, is essential to the prosperity of independents in Australia. 

“It’s absolutely vital,” he says. “By highlighting our unique patient journey, products and values, we can create a point-of-difference in our business. Having access to innovative, precise and world leading technology sets us apart as independents, allowing us to deliver exceptional clinical care.”  

More reading

Rodenstock Australia certified to fit Götti and Lindberg frames

New options for Rodenstock MyCon myopia lens wearers

Rodenstock expands glazing lab network with Tasmania site

Related Posts

Brothers Leo (left) and Steven Ho opened their practice in 2025. Images: Photo by Monday Media Joondalup

Two brothers, one vision come together in Perth

by Staff Writer
February 10, 2026

Two young optometrists are redefining early-career independence, launching a revitalised community practice in Perth and proving that ambition, teamwork and...

Researchers from the Children’s Hospital of Chongqing Medical University analysed 396 myopic children aged six to 12 years over 12 months. Image: Marc Calleja/ stock.adobe.com

DIMS lenses slow myopia without increasing astigmatism, study finds

by Staff Writer
February 10, 2026

Defocus incorporated multiple segments (DIMS) spectacle lenses can slow myopia progression in children without accelerating astigmatism, according to a prospective...

Soft contact lenses were rapidly becoming popular when Lyn Simeon started working in eyecare in the 1970s. Image: sergey Kolesnikov/Shutterstock.com

A front-row seat to a changing industry

by Lyn Simeon
February 9, 2026

With 55 years’ experience in the optical industry, LYN SIMEON shares her personal journey through the evolving world of contact...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited